▶ 調査レポート

世界の冠動脈ステント市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Coronary Stent Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の冠動脈ステント市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Coronary Stent Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A335資料のイメージです。• レポートコード:MRC2203A335
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の冠動脈ステント市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別(薬剤溶出性ステント、ベアメタル冠状動脈ステント、生体吸収性ステント)分析、生体材料別(金属生体材料、高分子生体材料、天然生体材料)分析、エンドユーザー別(病院、外来手術センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の冠動脈ステント市場規模:製品種類別(薬剤溶出性ステント、ベアメタル冠状動脈ステント、生体吸収性ステント)
・世界の冠動脈ステント市場規模:生体材料別(金属生体材料、高分子生体材料、天然生体材料)
・世界の冠動脈ステント市場規模:エンドユーザー別(病院、外来手術センター)
・世界の冠動脈ステント市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Abbott Laboratories、B. Braun Medical Inc.、Biosensors International Group Ltd、…)
・市場機会・将来傾向

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) increased in the past three decades in low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus, with the increased burden of CAD, the usage of coronary stents has increased significantly in healthcare facilities, as well as their production by the medical device manufacturers, thus helping in driving the market growth. In addition, the increasing geriatric population also increased the demand for coronary stents that are expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures, which significantly drives the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type, Expected to do Same Over the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

According to a survey conducted by European Heart Network in 2017, 3.9 million deaths in Europe were due to cardiovascular diseases. The increasing prevalence of cardiovascular diseases is also a major factor in the growth of the segment.

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market. According to the American College of Cardiology (2017), Cardiovascular disease accounts for 800,000 deaths in the United States. The increasing patient pool is boosting the market growth in the region.

Competitive Landscape

The major companies adopted strategies, like mergers and acquisitions and strategic alliances, to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
4.2.2 Rising of the Geriatric Population
4.2.3 Technological Advancements in Coronary Stents
4.3 Market Restraints
4.3.1 High Product Recalls
4.3.2 Stringent Approval Process for Stents
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Drug Eluting Stent
5.1.2 Bare Metal Coronary Stent
5.1.3 Bioabsorbable Stent
5.2 By Biomaterial
5.2.1 Mettalic Biomaterial
5.2.2 Polymeric Biomaterial
5.2.3 Natual Biomaterial
5.3 End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Medical Inc.
6.1.3 Biosensors International Group Ltd
6.1.4 BIOTRONIK SE & Co. KG
6.1.5 Boston Scientific Corporation
6.1.6 Cook Medical Technologies
6.1.7 Medtronic PLC
6.1.8 Terumo Corporation
6.1.9 Translumina GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS